# Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI

> **NCT00922623** · NA · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 93 (actual)

## Conditions studied

- Facial Wrinkles

## Interventions

- **DEVICE:** Belotero®

## Key facts

- **NCT ID:** NCT00922623
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2013-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922623, "Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00922623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
